EUVIMEDEUVIMED entdecken
Crossref

Integrating Metabolomics and Network Pharmacology to Explore the Active Compounds and Mechanism of Fructus Gardenia in Hyperuricemia

Huijuan Liu, Jiajia Wu, Nan Nan, Huimei Liu, Ronghui Mu, Fang Wang, Yiru Wang, Jiayin Song, Zihao Zhang, Xiaohui Wu, Xu Wang iD

Journal of Food Science · 2026

DOI: 10.1111/1750-3841.70795 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Food Science, 2026. Verfasst von Huijuan Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Gansu Medical College, Pingliang, China. Hauptthemen laut MEDLINE: Hyperuricemia, Gardenia. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Provincial Education Department of Gansu of China: University Teachers Innovation Fund Project, School Level Scientific Research Projects of Gansu Medical College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperuricemia (HUA) is becoming increasingly prevalent, and is associated with kidney dysfunction, metabolic issues, and heart disease. Fructus Gardenia (FG) has demonstrated a dual action of inhibiting uric acid (UA) production and enhancing its excretion, showing promise for treating HUA. We herein employ a combination of metabolomics and network pharmacology to explore the bioactive compounds and underlying mechanisms of FG in HUA. Upon oral administration of FG to HUA rats, serum UA levels, kidney function, and tissue changes were measured. Serum metabolomics was conducted to identify key metabolites and associated metabolic pathways. Network pharmacology and molecular docking were employed to reveal active compounds and their potential targets. Treatment with FG at a low dosage reduced the levels of UA and xanthine oxidase (XOD) to 39.7% and 54.1%, respectively, and ameliorated kidney damage induced by HUA. Xanthine dehydrogenase (XDH), hypoxanthine‐guanine phosphoribosyltransferase (HPRT1), purine nucleoside phosphorylase (PNP), catalase (CAT), and glycogen phosphorylase‐liver form (PYGL) were identified as the potential gene targets, which were linked to purine metabolism, inflammation, and oxidative stress. The activity of HPRT1, PNP, and PYGL was restored by FG administration, as well as the mRNA expression of P2X purinoceptor 7 (P2X7R) and solute carrier family 22 member 12 (SLC22A12). FG improves purine metabolism, reduces inflammation, and mitigates the risk of renal damage. These effects are achieved through the combined action of various compounds, including quercetin and ethyl oleate, involving the regulation of P2X7R and SLC22A12 expression, as well as the activities of XOD, HPRT1, PNP, and PYGL. Practical Applications As a natural food pigment, FG can be used to treat HUA and protect the kidney from damage caused by high UA levels, which is safe and effective within the recommended dosage. With further development into solid beverages or oral liquids, FG as a potential functional food and dietary supplement would meet the growing demand for natural management of UA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperuricemiaGardeniaAnimalsRatsRats, Sprague-DawleyUric AcidKidneyXanthine OxidasePurines

Stichwörter der Autor:innen

Fructus gardeniabioactive compoundsfunctional foodhyperuricemiametabolomicsnetwork pharmacology

Substanzen

Uric AcidXanthine OxidasePurines

Autor:innen und Institutionen

  • School of Pharmacy, Gansu Medical College, Pingliang, China.
  • School of Pharmacy, Tianjin Medical University, Tianjin, China.
  • Experimental Management Center, Shanxi University of Chinese Medicine, Taiyuan, China.

ORCID-Profile: Xu Wang

Förderung

  • National Natural Science Foundation of China
  • Provincial Education Department of Gansu of China: University Teachers Innovation Fund Project
  • School Level Scientific Research Projects of Gansu Medical College

Zitieren

APA

Liu, H., Wu, J., Nan, N., Liu, H., Mu, R., Wang, F., Wang, Y., Song, J., Zhang, Z., Wu, X., & Wang, X. (2026). Integrating Metabolomics and Network Pharmacology to Explore the Active Compounds and Mechanism of Fructus Gardenia in Hyperuricemia. Journal of Food Science. https://doi.org/10.1111/1750-3841.70795

Vancouver

Liu H, Wu J, Nan N, Liu H, Mu R, Wang F, et al. Integrating Metabolomics and Network Pharmacology to Explore the Active Compounds and Mechanism of Fructus Gardenia in Hyperuricemia. Journal of Food Science. 2026. doi:10.1111/1750-3841.70795

BibTeX
@article{Liu2026,
  author = {Liu, Huijuan and Wu, Jiajia and Nan, Nan and Liu, Huimei and Mu, Ronghui and Wang, Fang and Wang, Yiru and Song, Jiayin and Zhang, Zihao and Wu, Xiaohui and Wang, Xu},
  title = {Integrating Metabolomics and Network Pharmacology to Explore the Active Compounds and Mechanism of Fructus Gardenia in Hyperuricemia},
  journal = {Journal of Food Science},
  year = {2026},
  doi = {10.1111/1750-3841.70795}
}
Kostenlos starten →